Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines Read more
GOP state attorneys push back on Biden’s proposed diversity rules for apprenticeship programs Read more